Generic Drugs – Physician Perspective – Thematic Intelligence

Reasons to buy the ‘Generic Drugs – Physician Perspective’ thematic intelligence report:

• Assess healthcare professionals’ attitudes towards generic drugs prescription.
• Better understand the barriers to the production and uptake of generic medicines.
• Capture physicians’ opinions on generics substitution.
• Better understand patients’ preferences.
• Assess past and future generics uptake.
• Gain a better understanding of cost consideration when prescribing drugs.
• Explore the differences across markets.

How is our ‘Generic Drugs – Physician Perspective’ report unique from other reports in the market?

• This report combines information obtained from secondary sources and primary research with physicians from the 7MM. Polls from the readers of the Pharmaceutical Technology website are also included in the report.
• The report examines physician perception of generic medicines and provides insights into generics uptake, substitution patterns, and use across the seven major pharmaceutical markets.
• The report highlights the key players in the generic space and includes generics market size as well as growth forecast.

We recommend this valuable source of information to anyone involved in: 

• ​Pharmaceutical/Biotech/Drug Manufacturing Industries (Big Pharma, Small Biotech, Start-ups, etc.),
• Pharmaceutical Industry Suppliers (e.g., Consulting Companies, CMOs, CDMOs, CROs, Technology Vendors)
• Consulting and Professional Services (e.g., Investment Companies, Investment Banks, Equity Companies, etc.)
• Pharma Manufacturers/Distributors (Innovative, Biotech, Generics, Biosimilars, Rare/Orphan Disease)
• Financial Institutions (Investors in Pharma/Biotech, Pricing Consultancies)/Parallel Trade Organizations
• Healthcare Organizations (HTA Bodies, Reimbursement Groups and Payers, Government Healthcare Organizations)
• Clinical Research Organizations (CROs)

To Get a Snapshot of the Generic Drugs Thematic Report

Download a Free Report Sample

Generic Drugs Thematic Intelligence Report Overview

The report suggests that US physicians prescribed more generic drugs to more than 60% of its patients when compared to their counterparts in the five major European markets (France, Germany, Italy, Spain, and the UK). Italy had the lowest number recorded in the surveyed countries.

Even though physicians and pharmacists play a crucial role in drug choice, patient preferences should not be ignored. When patients have more information about their disease treatment, better outcomes can be achieved.

Many healthcare professionals (HCPs) believe that the adoption of generics will further increase in the next five years because of the growing penetration of generic drugs especially in more advanced markets. Therefore, they support substituting brand-name drugs with generic medicines. HCPs also opine that they would prefer to use branded drugs for their patients if cost was not the main factor.

The ‘generic drugs – physician perspective’ thematic intelligence report assesses the healthcare professionals’ attitudes towards generic drug prescriptions. It gives an understanding of the physician’s perception of generic medicines and the patient’s preferences. The report also explores the physicians’ perception of the use of generic drugs across the seven major pharmaceutical markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).

Generic Drugs – Current and Future Uptake

The US: Many HCPs in the US confirmed that they prescribe generic drugs to more than 61% of their patients. As the demand for drugs is increasing, governments are exerting pressure on doctors to prescribe cheaper generic medicines.

France: French physicians also indicated a strong uptake in generics use during the past five years and expected a further increase in the future. More than 34% of French HCPs reported using generic drugs. Physicians also confirmed the increasing trend in generic drug use during the past five years, and more than 60% of the survey respondents believed that generic uptake would increase in the next five years as well. This is the highest reported number across the surveyed countries.

Generic Drugs – Current and Future Uptake – The US

Buy the Full Report for More Insights on the Current and Future Uptake of Generic Drugs

Download a Free Sample Report

Generic Drugs – Physician’s Perspective

Physicians’ perceptions can also significantly influence patient choices. The countries covered to know the physician’s perspective towards generic evaluated here include the US, 5EU, and Japan.

Japan: The uptake of generic drugs in Japan has been slower. However, ongoing government initiatives are helping to increase the utilization of generic medicines in this market. A significant percentage of physicians in Japan agreed that patients prefer branded drugs over generics. This common finding across all countries researched suggests that governments and physicians may need to engage more in patient education to address the patients’ misconceptions.

Buy the Full Report for More Insights on the Physician’s Attitude towards Generic Drugs

Download a Free Sample Report

Key Highlights

• Generic drugs provide a good opportunity to increase efficiency in pharmaceutical spending.
• Patient and physician education on generics is necessary to boost generics uptake.
• Generic drug penetration has reached its zenith in most of the advanced pharmaceutical markets.